H. E. Feucht, H. Schneeberger, and G. Hillebrand, Capillary deposition of C4d complement fragment and early renal graft loss, Kidney Int, vol.43, p.1333, 1993.

M. Mengel, B. Sis, and M. Haas, Meeting report: new concepts in antibody-mediated rejection, Am J Transpl, vol.12, p.563, 2011.

C. Lefaucheur, A. Loupy, and D. Vernerey, Antibody-mediated vascular rejection of kidney allografts: a population-based study, Lancet, vol.381, p.313, 2013.

A. Loupy, C. Suberbielle-boissel, and G. S. Hill, Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies, Am J Transpl, vol.9, p.2561, 2009.

H. M. Gebel, P. W. Nickerson, and A. A. Zachary, Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation, Transplantation, vol.95, p.19, 2013.

A. Loupy, C. Lefaucheur, and D. Vernerey, Complement-binding anti-HLA antibodies and kidney-allograft survival, N Engl J Med, vol.369, p.1215, 2013.

M. Hourmant, A. Cesbron-gautier, and P. I. Terasaki, Frequency and clinical implications of development of donor-specific and nondonor-specific HLA antibodies after kidney transplantation, J Am Soc Nephrol, vol.16, p.2804, 2005.

C. Lefaucheur, D. Nochy, and G. S. Hill, Determinants of poor graft outcome in patients with antibody-mediated acute rejection, Am J Transpl, vol.7, p.832, 2007.

S. Mohan, A. Palanisamy, and D. Tsapepas, Donor-specific antibodies adversely affect kidney allograft outcomes, J Am Soc Nephrol, vol.23, p.2061, 2012.

A. R. Tambur, S. V. Pamboukian, and M. R. Costanzo, The presence of HLAdirected antibodies after heart transplantation is associated with poor allograft outcome, Transplantation, vol.80, p.1019, 2005.

D. Cantarovich, S. De-amicis, and A. Akl, Post transplantation donorspecific anti-HLA antibodies negatively impact pancreas transplantation outcome, Am J Transpl, vol.12, p.2737, 2011.

C. Lefaucheur, C. Suberbielle-boissel, and G. S. Hill, Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation, Contrib Nephrol, vol.162, p.1, 2009.

M. J. Everly, J. J. Everly, and B. Susskind, Proteasome inhibition reduces donor-specific antibody levels, Transpl Proc, vol.41, p.105, 2009.

M. J. Everly, J. J. Everly, and L. J. Arend, Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss, Am J Transpl, vol.9, p.1063, 2009.

C. Dorje, K. Midtvedt, and H. Holdaas, Early versus late acute antibodymediated rejection in renal transplant recipients, Transplantation, vol.96, p.79, 2013.

C. Wiebe, I. W. Gibson, and T. D. Blydt-hansen, Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant, Am J Transpl, vol.12, p.1157, 2012.

V. Kosmoliaptsis, J. A. Bradley, and S. Peacock, Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies, Transplantation, vol.87, p.813, 2009.

M. Schnaidt, C. Weinstock, and M. Jurisic, HLA antibody specification using single-antigen beads-a technical solution for the prozone effect, Transplantation, vol.92, p.510, 2011.

H. Kaneku, J. G. O'leary, and N. Banuelos, De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients, Am J Transpl, vol.13, p.1541, 2013.

M. J. Everly, L. M. Rebellato, and C. E. Haisch, Incidence and impact of de novo donor-specific alloantibody in primary renal allografts, Transplantation, vol.95, p.410, 2012.

M. Matignon, T. Muthukumar, and S. V. Seshan, Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with c4d-positive antibody-mediated rejection, Transplantation, vol.94, p.603, 2012.

F. G. Cosio, J. M. Gloor, and S. Sethi, Transplant glomerulopathy, Am J Transplant, vol.8, p.492, 2008.

E. Volpe, M. Touzot, and N. Servant, Multiparametric analysis of cytokinedriven human Th17 differentiation reveals a differential regulation of IL-17 and IL-22 production, Blood, vol.114, p.4, 2009.